Literature DB >> 9053977

Back pain in patients with ductal pancreatic cancer. Its impact on resectability and prognosis after resection.

G J Ridder1, J Klempnauer.   

Abstract

BACKGROUND: Back pain is a frequent and often ominous clinical sign in patients with ductal pancreatic cancer.
METHODS: From 1971 to 1993 a pancreatic carcinoma could be resected in 192 patients, whereas 261 patients underwent either probatory laparotomy alone or palliative bypass procedures. In a retrospective study including uni- and multi-variate survival analysis we have determined the impact of preoperative back pain on both resectability and long-term prognosis after resection.
RESULTS: Among the presenting symptoms of patients with ductal pancreatic cancer back pain was a predictive sign of irresectability. In the presence of preoperative back pain the long-term prognosis after resection of the tumour was also significantly impaired. In a multivariate analysis it could be demonstrated that the prognostic impact of back pain was as strong as the influence of residual tumour, tumour grading, and tumour size.
CONCLUSIONS: Back pain often indicates irresectability of ductal pancreatic carcinoma and also impairs the long-term prognosis even after curative resection.

Entities:  

Mesh:

Year:  1995        PMID: 9053977     DOI: 10.3109/00365529509101634

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  8 in total

Review 1.  Indications for staging laparoscopy in pancreatic cancer.

Authors:  Antonella De Rosa; Iain C Cameron; Dhanwant Gomez
Journal:  HPB (Oxford)       Date:  2015-11-18       Impact factor: 3.647

2.  Resection of non-cystic adenocarcinoma in pancreatic body and tail.

Authors:  Hai-Chao Yan; Yu-Lian Wu; Li-Rong Chen; Shun-Liang Gao
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

3.  Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage.

Authors:  Miquel Porta; Xavier Fabregat; Núria Malats; Luisa Guarner; Alfredo Carrato; Ana de Miguel; Laura Ruiz; Manuel Jariod; Sergi Costafreda; Susana Coll; Juan Alguacil; Josep M Corominas; Ricard Solà; Antonio Salas; Francisco X Real
Journal:  Clin Transl Oncol       Date:  2005-06       Impact factor: 3.405

Review 4.  Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.

Authors:  Chakshu Sharma; Karim M Eltawil; Paul D Renfrew; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

5.  McGill Brisbane Symptom Score for patients with resectable pancreatic head adenocarcinoma.

Authors:  Mohammed H Jamal; Suhail A R Doi; A James Moser; Sinziana Dumitra; Jad abou Khalil; Eve Simoneau; Prosanto Chaudhury; Adedayo A Onitilo; Peter Metrakos; Jeffrey S Barkun
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

6.  Impact of celiac neurolysis on survival in patients with pancreatic cancer.

Authors:  Larissa L Fujii-Lau; William R Bamlet; Jason S Eldrige; Suresh T Chari; Ferga C Gleeson; Barham K Abu Dayyeh; Jonathan E Clain; Randall K Pearson; Bret T Petersen; Elizabeth Rajan; Mark D Topazian; Santhi S Vege; Kenneth K Wang; Maurits J Wiersema; Michael J Levy
Journal:  Gastrointest Endosc       Date:  2015-03-20       Impact factor: 9.427

7.  Preoperative staging and evaluation of resectability in pancreatic ductal adenocarcinoma.

Authors:  R Andersson; C E Vagianos; R C N Williamson
Journal:  HPB (Oxford)       Date:  2004       Impact factor: 3.647

8.  Development and multicentre validation of a prognostic model to predict resectability of pancreatic head malignancy.

Authors:  K Gerken; K J Roberts; B Reichert; R P Sutcliffe; F Marcon; S K Kamarajah; A Kaltenborn; T Becker; N G Heits; D F Mirza; J Klempnauer; H Schrem
Journal:  BJS Open       Date:  2018-06-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.